These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 469929)

  • 1. Passive protection by human serum in mice infected with encapsulated Staphylococcus aureus.
    Yoshida K; Ichiman Y; Narikawa S; Takahashi M; Kono E; San Clemente CL
    J Med Microbiol; 1979 Aug; 12(3):277-82. PubMed ID: 469929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective antibodies in human sera against encapsulated strains of Staphylococcus epidermidis.
    Ichiman Y; Yamada T; Yoshida K
    J Appl Bacteriol; 1987 Aug; 63(2):165-9. PubMed ID: 3654405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological response to a strain of Staphylococcus epidermidis in the rabbit: production of protective antibody.
    Yoshida K; Ichiman Y
    J Med Microbiol; 1978 Nov; 11(4):371-7. PubMed ID: 722780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of mice by a pseudodiffuse strain of Staphylococcus aureus possessing polyvalent capsular type antigen.
    Chomarat M; Ichiman Y; Yoshida K
    J Med Microbiol; 1989 Feb; 28(2):129-36. PubMed ID: 2915365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective activity of two human intravenous immunoglobulin preparations in experimental infection with an encapsulated Staphylococcus aureus strain.
    Vassilev T; Petrova R; Bozadjiev L; Peeva Z; Bineva I
    Acta Microbiol Hung; 1987; 34(2):139-45. PubMed ID: 3439436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The characterization of antibacterial antibodies in bovine immune sera to Staphylococcus aureus.
    Yokomizo Y; Isayama Y
    Microbiol Immunol; 1978; 22(1):1-13. PubMed ID: 661625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoglobulins in the hyperimmunoglobulin E and recurrent infection (Job's) syndrome. Deficiency of anti-Staphylococcus aureus immunoglobulin A.
    Dreskin SC; Goldsmith PK; Gallin JI
    J Clin Invest; 1985 Jan; 75(1):26-34. PubMed ID: 3871199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Passive immunization against Pseudomonas with a ribosomal vaccine-induced immune serum and immunoglobulin fractions.
    Lieberman MM; McKissock DC; Wright GL
    Infect Immun; 1979 Feb; 23(2):509-21. PubMed ID: 106013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Passive protective activities of human sera against infection with strain ST67P of Staphylococcus hyicus].
    Hanawa N
    Kansenshogaku Zasshi; 1990 Aug; 64(8):957-62. PubMed ID: 2212764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial cell wall-expressed protein A triggers supraclonal B-cell responses upon in vivo infection with Staphylococcus aureus.
    Palmqvist N; Silverman GJ; Josefsson E; Tarkowski A
    Microbes Infect; 2005 Dec; 7(15):1501-11. PubMed ID: 16039897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of human serum antibody to encapsulated strains of Staphylococcus aureus by enzyme-linked immunosorbent assay inhibition test.
    Ueda H; Matsushita K; Ichiman Y
    J Orthop Sci; 1998; 3(2):95-101. PubMed ID: 9654562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross protection between an encapsulated strain of Staphylococcus hyicus and encapsulated strains of Staphylococcus aureus.
    Yoshida K; Ichiman Y; Umeda A
    J Appl Bacteriol; 1988 Dec; 65(6):491-9. PubMed ID: 3243729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purified capsular polysaccharide-induced immunity to Staphylococcus aureus infection.
    Lee JC; Perez NE; Hopkins CA; Pier GB
    J Infect Dis; 1988 Apr; 157(4):723-30. PubMed ID: 3346565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of immunoglobulin classes of antibodies against Coxiella burnetii by protein A from Staphylococcus aureus.
    Tokarevich NK; Zhebrun AV; Khazenson SL; Roshchina NG
    Acta Virol; 1980 May; 24(3):218-21. PubMed ID: 6107038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative aspects of binding of canine serum immunoglobulins of Staphylococcus aureus protein A.
    Miele JA; Krakowka S
    Am J Vet Res; 1981 Dec; 42(12):2065-7. PubMed ID: 6803618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of Serratia marcescens to human serum: antagonism of serum bactericidal activity by IgG immunoglobulins of homologous rabbit anti-O sera.
    Traub WH
    Zentralbl Bakteriol A; 1980 Feb; 246(1):26-49. PubMed ID: 6158811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successive extraction of specific protective immunoglobulins from pooled human sera.
    Yoshida K; Ichiman Y
    J Clin Microbiol; 1984 Sep; 20(3):461-4. PubMed ID: 6386863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody studies in a rabbit model of corneal phlyctenulosis and catarrhal infiltrates related to Staphylococcus aureus.
    Mondino BJ; Adamu SA; Pitchekian-Halabi H
    Invest Ophthalmol Vis Sci; 1991 May; 32(6):1854-63. PubMed ID: 2032807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective opsonic activity of antibodies against fibronectin-binding proteins (FnBPs) of Staphylococcus aureus.
    Rozalska B; Wadström T
    Scand J Immunol; 1993 May; 37(5):575-80. PubMed ID: 8484103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunity to staphylococcal infection in mice: effect of living versus killed vaccine, role of circulating antibody, and induction of protection-inducing antigen(s) in vitro.
    Ekstedt RD; Yoshida K
    J Bacteriol; 1969 Nov; 100(2):745-50. PubMed ID: 5354944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.